barrier
tissu
epithelia
play
essenti
role
maintain
organism
homeostasi
chang
cellular
composit
observ
multipl
human
diseas
within
small
intestin
epithelium
adult
stem
cell
integr
divers
signal
regul
regener
differenti
therebi
establish
overal
cellular
accordingli
direct
stem
cell
differenti
could
provid
tractabl
approach
alter
abund
qualiti
special
cell
small
intestin
epithelium
includ
secretori
paneth
goblet
enteroendocrin
popul
yet
date
lack
suitabl
tool
rigor
approach
identifi
biolog
target
pharmacolog
agent
modifi
epitheli
composit
enabl
causal
test
diseaseassoci
chang
novel
therapeut
candid
empow
search
epitheliamodifi
agent
establish
firstofitskind
highthroughput
phenotyp
organoid
screen
demonstr
abil
screen
thousand
sampl
uncov
biolog
target
associ
small
molecul
inhibitor
translat
vivo
approach
enabl
employ
function
celltyp
specif
scalabl
assay
organoid
model
design
repres
physiolog
cue
vivo
paneth
cell
differenti
adult
intestin
stem
cell
miniatur
adapt
organoid
cultur
system
enabl
autom
plate
screen
therebi
provid
abil
test
thousand
sampl
strikingli
screen
identifi
inhibitor
nuclear
export
modul
stem
cell
fate
commit
induc
panepitheli
stress
respons
combin
interrupt
mitogen
signal
cycl
intestin
progenitor
therebi
significantli
increas
abund
paneth
cell
independ
known
wnt
notch
differenti
cue
extend
observ
vivo
demonstr
oral
administr
inhibitor
dose
lower
convent
use
hematolog
malign
increas
paneth
cell
abund
total
provid
framework
identifi
novel
biolog
cue
therapeut
lead
rebal
intestin
stem
cell
differenti
modul
epitheli
tissu
composit
via
highthroughput
phenotyp
screen
rationallydesign
organoid
model
differenti
epitheli
barrier
tissu
enabl
interact
exchang
protect
extern
environ
vital
function
accomplish
special
epitheli
cell
integr
stromal
immun
cell
popul
within
small
intestin
adult
intestin
stem
cell
isc
convent
identifi
marker
includ
barker
et
al
van
der
flier
et
al
provid
sourc
constant
regener
order
process
differenti
secretori
absorpt
epitheli
cell
determin
composit
therebi
steer
barrier
function
homeostat
condit
wnt
bmp
notch
signal
activ
maintain
isc
nich
kim
et
al
pinto
et
al
howev
isc
demonstr
capac
integr
dietari
immunederiv
signal
modul
selfrenew
differenti
specif
secretori
lineag
beyaz
et
al
biton
et
al
von
moltk
et
al
follow
injuri
isc
nich
remark
capac
regener
nonstem
quiescent
stem
pool
ayyaz
et
al
tetteh
et
al
yan
et
al
cellular
ident
stem
cell
nich
fluid
respons
physiolog
patholog
stimuli
rouli
et
al
barrier
tissu
upper
respiratori
tract
skin
chang
epitheli
composit
aris
aberr
stem
cell
differenti
naik
et
al
ordovasmontan
et
al
may
precipit
factor
infalmmatori
diseas
addit
shift
composit
qualiti
matur
epitheli
cell
descend
isc
known
occur
colon
small
intestin
patient
suffer
inflammatori
bowel
diseas
graham
xavier
smilli
et
al
given
barrier
tissu
stem
cell
possess
signific
control
cellular
composit
may
provid
restor
tissu
homeostasi
broad
spectrum
human
diseas
compel
target
therapeut
develop
support
discoveri
effort
focus
modul
restor
epitheli
barrier
composit
need
tool
identifi
druggabl
biolog
target
involv
regul
epitheli
differenti
tool
employ
physiologicallyrepres
model
barrier
provid
best
opportun
identifi
biolog
target
may
translat
vivo
context
also
recapitul
cell
differenti
process
scalabl
robustli
measur
fashion
intestin
organoidsbroadli
defin
threedimension
stem
cellderiv
tissuelik
cellular
structureshav
proven
valuabl
model
adult
stem
cell
nich
preserv
known
development
pathway
stem
cell
differenti
sato
et
al
yin
et
al
howev
organoid
model
dynam
cellularli
structur
heterogen
typic
requir
complex
costli
experiment
manipul
applic
phenotyp
highthroughput
screen
limit
screen
activ
organoid
model
multipl
tissu
far
either
focus
clear
geneticallydriven
behavior
dekker
et
al
korv
et
al
screen
capac
demonstr
order
ten
perturb
czerniecki
et
al
foundat
step
toward
har
organoid
screen
model
yet
provid
novel
biolog
target
discoveri
translat
nativ
vivo
tissu
one
approach
adapt
organoid
phenotyp
highthroughput
screen
reduct
model
complex
around
wellstructur
hypothesi
incorpor
link
vivo
tissu
biolog
mead
karp
exist
chemic
tool
small
intestin
organoid
may
enabl
approach
addit
wellcharacter
small
molecul
cultur
media
provid
enrich
intestin
organoid
isc
drive
differenti
specif
lineag
provid
physiologicallymeaning
cue
modul
wnt
notch
signal
yin
et
al
use
rationallydirect
differenti
appli
induc
function
paneth
cell
enrich
isc
vitro
mead
et
al
employ
small
molecul
mimic
known
vivo
signal
cue
physiolog
differenti
stem
cell
becom
possibl
construct
organoid
repres
lineagespecif
stem
cell
differenti
frame
screen
campaign
around
identifi
new
biolog
target
may
modul
differenti
instanc
identif
biolog
target
accompani
small
molecul
enhanc
paneth
cell
differenti
isc
search
novel
target
enhanc
paneth
cell
differenti
increas
abund
nativ
tissu
may
therapeut
valuabl
declin
paneth
cell
qualiti
number
observ
inflammatori
bowel
diseas
ibd
gassler
khor
et
al
liu
et
al
mcguckin
et
al
xavier
podolski
similar
paneth
cell
aberr
occur
necrot
enterocol
nec
correspond
intestin
immatur
excess
inflamm
system
infect
mcelroy
et
al
sherman
et
al
tanner
et
al
white
et
al
emerg
evid
suggest
certain
viral
pathogen
includ
subset
coronaviru
may
mediat
disrupt
intestin
barrier
target
deplet
paneth
cell
wu
et
al
final
patient
graft
versu
host
diseas
gvhd
exhibit
loss
paneth
cell
number
qualiti
associ
microbi
dysbiosi
eriguchi
et
al
addit
treatment
potenti
wnt
signal
elev
secret
panethspecif
alphadefensin
resolv
dysbiosi
seen
mice
gvhd
stimul
isc
differenti
paneth
cell
hayas
et
al
treatment
illustr
import
stem
cell
cue
drive
barrier
tissu
reconstitut
face
major
challeng
clinic
translat
wnt
activ
implic
precancer
hyperplasia
okubo
hogan
sansom
et
al
signal
pathway
known
drive
paneth
cell
differenti
includ
notch
signal
face
similar
challeng
activ
notch
signal
amplifi
prolif
progenitor
popul
promot
absorpt
cell
lineag
fre
et
al
jensen
et
al
vandussen
et
al
convers
deactiv
notch
signal
amplifi
differenti
secretori
cell
type
secretori
cell
hyperplasia
vandussen
samuelson
specif
nich
factorindepend
treatment
accomplish
isctopaneth
differenti
could
provid
safer
modul
tissu
composit
direct
isc
preferenti
differenti
paneth
cell
independ
known
nich
signal
wnt
notch
offer
specif
hypothesi
compel
therapeut
target
accordingli
sought
adapt
scale
organoid
model
screen
pharmaceuticallyaction
biolog
target
mediat
isctopaneth
differenti
independ
major
nicheassoci
pathway
screen
novel
biolog
target
establish
pharmacophor
may
regul
paneth
cell
differenti
vitro
translat
vivo
requir
physiolog
model
system
scalabl
screen
approach
reason
scan
annot
small
molecul
space
thousand
sampl
measur
specif
chang
singl
cell
type
paneth
cell
within
dynam
differenti
heterogen
organoid
system
model
physiologicallydriven
paneth
cell
differenti
employ
method
small
moleculemedi
enrich
differenti
intestin
organoid
isc
paneth
cell
murin
intestin
organoid
typic
expand
matrigel
scaffold
supplement
cultur
media
contain
growth
factor
intend
mimic
isc
nich
epiderm
growth
factor
e
bmpantagonist
noggin
n
aforement
wntpathway
enhanc
r
spontan
differenti
organoid
grown
enr
media
mitig
popul
isc
enrich
addit
small
molecul
c
activ
wnt
signal
valproic
acid
v
activ
notch
signal
iscenrich
cultur
differenti
toward
paneth
cell
small
molecul
c
dapt
inhibitor
notch
signal
previous
shown
mead
et
al
yin
et
al
measur
chang
paneth
cell
abund
qualiti
employ
previous
demonstr
assay
paneth
cellspecif
function
relativeabund
commerciallyavail
assay
secret
lysozym
lyz
mead
et
al
scale
model
system
measur
adapt
convent
organoid
cultur
pseudomonolay
iscenrich
organoid
partial
embed
surfac
thick
layer
matrigel
matrigelmedia
interfac
rather
fulli
encapsul
matrigel
structur
approach
similar
other
previous
report
langhan
techniqu
enabl
matrigel
plate
cell
seed
media
addit
perform
highthroughput
fullyautom
plate
format
allow
lyz
secret
directli
cell
cultur
media
therebi
enhanc
measur
sensit
test
approach
screen
small
molecul
librari
contain
wellannot
specif
small
molecul
inhibitor
divers
rang
biolog
target
supp
tabl
differenti
start
iscenrich
organoid
precursor
n
biolog
replic
origin
uniqu
murin
donor
small
molecul
ad
distinct
well
concentr
per
compound
nm
rang
day
day
day
measur
function
secret
lyz
media
supernat
specif
marker
paneth
cell
enrich
fig
paneth
cell
abund
determin
measur
basal
secret
lyz
lyzn
follow
carbachol
cch
induc
secret
lyz
along
cellular
atp
measur
rel
cell
number
per
well
chose
assay
stimulantinduc
lyz
total
cellular
lyz
basal
lyzn
constitut
secret
lyz
secret
distinguish
compound
may
mediat
chang
paneth
cell
qualiti
secret
lyzn
lyz
uncorrel
versu
chang
paneth
cell
abund
lyzn
lyz
correl
targetselect
inhibitor
librari
contain
compound
high
specif
uniqu
molecular
targetsmani
implic
stem
cell
differenti
total
proofofconcept
screen
assay
uniqu
sampl
function
assay
first
sought
demonstr
screen
approach
reproduc
assay
measur
meaning
function
scale
follow
normal
measur
well
assay
approximatenorm
distribut
lowervalu
tail
correspond
toxic
compound
supp
fig
assay
valu
across
biolog
replic
well
correl
pearson
correl
valu
screen
plate
rang
supp
fig
valid
multiplex
assay
perform
screen
assess
assay
perform
base
untreat
control
well
randomlydistribut
screen
plate
control
well
significantli
higher
atp
read
nocel
well
adj
p
lyzn
subsequ
lyz
assay
supernat
lyz
significantli
higher
cchstimul
control
well
basal
control
well
lyzn
adj
p
lyz
adj
p
turn
significantli
higher
nocel
well
lyzn
adj
p
lyz
adj
p
supp
fig
follow
confirm
reason
plate
reproduc
assay
perform
next
sought
defin
molecul
meaning
increas
paneth
cell
abund
defin
primari
screen
hit
replic
strictli
standard
mean
differ
ssmd
lyzn
lyz
assay
greater
calcul
optim
critic
valu
fig
determin
intersect
minim
fals
posit
fals
neg
level
fpl
fnl
error
upregul
ssmdbase
decis
zhang
hit
correspond
treatmentdos
group
biolog
replic
combin
statist
signific
increas
lyzn
lyz
without
regard
viabil
though
hit
per
criteria
posit
effect
cellular
atp
hit
narrow
treatmentdos
combin
use
zscore
foldchang
select
combin
elicit
biolog
effect
top
valu
lyz
assay
rel
plate
z
score
thu
drug
cover
treatmentdos
condit
uniqu
molecular
target
identifi
primari
screen
hit
fig
molecular
target
one
hit
robust
treatmentdos
select
investig
valid
primari
screen
hit
enrcd
plate
control
identifi
appropri
doserespons
rang
narrow
hit
potent
activ
paneth
cell
differenti
perform
secondari
screen
primari
screen
hit
compound
compound
test
narrow
dose
rang
around
treatment
identifi
optim
dose
primari
screen
hit
valid
screen
chosen
ssmd
lyzn
lyz
assay
greater
calcul
optim
critic
valu
compound
pass
threshold
supp
fig
treatmentdos
condit
pass
ssmd
threshold
also
greatest
biolog
effect
particular
one
compound
known
inhibitor
two
dose
repres
greatest
neargreatest
biolog
effect
increas
lyzn
lyz
rel
enrcd
control
fig
result
primari
secondari
screen
reflect
mixtur
potenti
effect
may
caus
increas
total
lyz
secret
includ
contribut
enhanc
paneth
cell
differenti
alter
paneth
cell
qualiti
chang
total
cell
number
concurr
differenti
better
inform
compound
increas
total
secret
lyz
isol
enhanc
paneth
differenti
robustli
util
flow
cytometri
measur
chang
paneth
cell
represent
within
treat
organoid
differenti
concurr
ensur
select
compound
manifest
behavior
specif
vitro
set
perform
analys
convent
cultur
method
thu
provid
control
cultur
systemspecif
effect
singl
live
cell
select
sever
gate
strategi
paneth
cell
identifi
lyzhigh
side
scatterhigh
sschigh
supp
fig
one
compound
potent
compound
valid
screen
significantli
enhanc
matur
paneth
cell
popul
within
differenti
organoid
suggest
induc
paneth
differenti
fig
remain
compound
nilotinib
exclud
none
chang
organoid
composit
like
drive
chang
paneth
qualiti
mediat
effect
depend
cultur
nilotinib
significantli
decreas
paneth
abund
significantli
increas
total
cell
number
suggest
overal
increas
bulk
lyz
secret
effect
increas
prolifer
effect
examin
whether
hit
depend
independ
canon
stem
cell
nich
signal
next
evalu
whether
cultur
media
supplement
c
mimic
physiolog
paneth
differenti
wnt
activ
notch
inhibit
may
alter
effect
hit
measur
paneth
cell
abund
canon
enr
cultur
condit
nb
paneth
cell
exist
immatur
state
within
enr
unabl
robustli
quantifi
paneth
cell
number
via
flow
cytometri
instead
use
lyz
secret
assay
result
mirror
flow
cytometri
find
enrcd
condit
suggest
identifi
compound
act
independ
strong
wnt
notch
driver
enhanc
paneth
cellspecif
activ
convent
organoid
cultur
condit
suppl
fig
collect
result
led
us
focu
sole
potenti
mechan
inhibit
next
sought
confirm
predict
ontarget
activ
investig
dosedepend
treatment
enhanc
paneth
cell
differenti
firstinclass
orallyadminist
fdaapprov
drug
multipl
myeloma
target
nuclear
transport
also
known
administr
nm
day
nb
higher
concentr
prove
toxic
primari
screen
show
lyz
secret
increas
dosedepend
manner
nm
effect
dose
among
test
concentr
select
inhibitor
nuclear
export
sine
molecul
act
suppress
nuclear
export
multipl
protein
mrna
nucleu
cytoplasm
includ
gene
involv
stem
cell
mainten
differenti
well
inflammatori
stress
respons
sendino
et
al
protein
shuttl
mark
nuclear
export
signal
ne
addit
known
regul
cell
cycl
exportindepend
role
regul
mitosi
forb
et
al
base
evid
hypothes
inhibit
might
provid
enhanc
paneth
cell
differenti
direct
isc
modul
differenti
trajectori
alter
either
development
signal
within
nucleu
interf
cell
cycl
test
hypothesi
drive
paneth
differenti
alter
isc
behavior
util
singlecel
rnasequenc
scrnaseq
via
seqwel
hugh
et
al
perform
longitudin
comparison
untreat
organoid
differenti
particular
emphasi
earli
timepoint
fig
collect
sampl
follow
timepoint
hour
day
day
sampl
consist
singl
cell
organoid
predifferenti
enrcv
organoid
enrcd
enrcd
nm
condit
time
point
beyond
day
media
refresh
everi
day
result
dataset
consist
cell
uniqu
molecular
identifi
umi
percent
mitochondri
detect
gene
distribut
similar
across
sampl
within
accept
qualiti
bound
gene
umi
percent
mitochondri
supp
fig
tabl
cluster
possess
similar
qualiti
metric
suggest
cluster
driven
biolog
technic
differ
supp
fig
contextu
provid
robust
measur
cellular
ident
cluster
use
lineagedefin
gene
set
murin
small
intestin
scrnaseq
atla
haber
et
al
score
enrich
gene
set
express
supp
fig
eight
cluster
includ
three
stemlik
two
enterocyt
two
paneth
one
enteroendocrin
align
expect
enrcd
differenti
enrich
secretori
epithelium
cell
princip
paneth
lesser
extent
enteroendocrin
fig
distinguish
three
stemlik
cluster
assess
physiolog
relev
perform
modul
score
gene
set
identifi
correspond
known
isc
subset
vivo
biton
et
al
supp
fig
see
align
type
iii
type
isc
per
nomenclatur
biton
et
al
along
slight
enrich
distinct
type
ii
supp
fig
though
popul
may
also
intermedi
stem
iii
popul
share
marker
fig
accordingli
adopt
name
scheme
biton
et
al
next
explor
chang
cell
type
represent
organoid
treat
versu
control
importantli
combin
dataset
observ
cell
cluster
uniqu
treatment
rather
shift
cluster
composit
supp
fig
condit
begin
cell
either
stem
ii
stem
iii
day
stem
emerg
account
approxim
cell
control
condit
smaller
proport
organoid
earli
enterocyt
emerg
day
continu
differenti
enterocyt
peak
day
becom
less
preval
day
earli
paneth
popul
appear
crest
enterocyt
follow
transit
paneth
cell
continu
day
fig
better
quantifi
differ
represent
control
condit
time
perform
fisher
exact
test
cell
type
rel
other
done
timepoint
cell
type
account
least
cell
control
sampl
present
rel
enrich
deplet
cell
popul
treatment
time
odd
ratio
correspond
confid
interv
treatment
lead
deplet
stem
ii
iii
enteroendocrin
cell
time
along
correspond
enrich
enterocyt
paneth
cell
fig
observ
twofold
enrich
paneth
cell
day
mirror
flow
cytometri
observ
twofold
increas
matur
paneth
cell
also
show
unexpect
earli
enrich
enterocyt
longerterm
deplet
subset
stem
cell
quiescent
stem
popul
composit
chang
differenti
consist
inhibit
act
prodifferenti
manner
data
suggest
stem
ii
iii
popul
may
primari
target
untreat
organoid
express
significantli
enrich
cycl
stem
iii
popul
fig
supp
fig
express
gene
known
contain
ne
requir
nuclear
efflux
via
fu
et
al
specif
know
mediat
nuclear
signal
process
includ
mitogenactiv
protein
kinas
mapk
pathway
nfat
aurora
kinas
activ
cell
divis
sendino
et
al
mind
observ
express
mani
key
mediat
pathway
within
stem
popul
see
particular
stem
iiienrich
member
mapk
nfat
aurora
kinas
aurka
aurkb
supp
fig
explor
whether
stem
ii
iii
popul
princip
cellular
target
inhibit
leverag
dynam
natur
system
expos
organoid
everi
interv
differenti
measur
final
abund
function
matur
paneth
cell
day
therebi
infer
rel
effect
inhibit
cell
type
fig
treatment
day
result
greatest
enrich
matur
paneth
cell
longer
exposur
follow
day
provid
addit
albeit
lesser
enrich
day
treatment
produc
moder
enrich
day
differ
untreat
flow
cytometri
slightli
enrich
lyz
secret
assay
fig
supp
fig
use
addit
sine
observ
similar
enrich
behavior
supp
fig
data
consist
inhibit
alter
stem
ii
iii
differenti
largest
effect
inhibit
concurr
period
differenti
cours
stem
ii
iii
popul
abund
howev
data
also
suggest
inhibit
may
entir
stemdepend
given
lesser
signific
increas
paneth
cell
number
function
later
treatment
stem
ii
iii
popul
greatli
diminish
better
understand
pleiotrop
effect
inhibit
may
mediat
differenti
examin
differenti
express
gene
treat
untreat
stem
ii
iii
popul
earliest
stage
differenti
abund
day
significantli
enrich
deplet
tabl
addit
notabl
gene
significantli
increas
express
includ
regul
prolif
process
growth
inhibitor
regul
stress
respons
isc
cheng
et
al
draheim
et
al
jadhav
zhang
zhou
et
al
gene
downregul
treatment
appear
relat
prolifer
cell
cycl
includ
marker
addit
substanti
chang
within
earli
stem
ii
iii
popul
gene
regul
inhibit
includ
increas
express
across
cell
type
time
signific
differ
fraction
cell
express
gene
supp
fig
suggest
stem
ii
iii
specif
respons
panepitheli
respons
inhibit
better
contextu
transcript
respons
treatment
stem
ii
iii
cell
perform
gene
set
enrich
analys
gsea
use
molecular
signatur
databas
msigdb
hallmark
collect
repres
specif
welldefin
biolog
state
process
across
system
liberzon
et
al
subramanian
et
al
signific
gene
set
fdr
reveal
two
major
program
differenti
next
examin
whether
respons
embodi
signific
differentiallyexpress
gene
stem
ii
iii
day
may
panepitheli
restrict
cycl
stem
ii
iii
popul
stress
respons
modul
differenti
increas
stem
ii
iii
substanti
increas
across
cell
differenti
greatest
effect
stem
ii
iii
well
earli
matur
cell
popul
lowest
effect
matur
paneth
cell
fig
convers
mitogen
signal
modul
differenti
decreas
stem
ii
iii
select
decreas
stem
ii
iii
earli
enterocyt
popul
rel
other
select
correspond
observ
major
mitogen
signal
occur
within
prolif
stem
ii
iii
popul
rel
matur
popul
evid
alter
mitogen
signal
impact
stem
ii
iii
cell
follow
inhibit
observ
decreas
sought
clarifi
conceptu
model
use
addit
small
molecul
inhibitor
known
modul
discret
compon
hypothes
differenti
process
name
signal
stress
respons
includ
signal
within
mapk
pathway
final
effect
mitosi
associ
aurora
kinas
began
treat
organoid
along
enrcd
differenti
cours
small
molecul
inhibitor
test
whether
critic
sineinduc
stress
respons
alon
combin
observ
significantli
decreas
function
lyz
secret
end
differenti
combin
alon
fig
suggest
signal
import
mediat
paneth
differenti
isc
next
test
whether
downstream
mediat
inhibit
repeat
assay
two
known
modul
inhibitor
pifithrina
pfta
agonist
serdemetan
serd
across
wide
doserang
modul
test
alter
paneth
cell
differenti
neither
alon
combin
stress
respons
depend
signal
modul
either
compound
supp
fig
assay
began
probe
mitogen
signal
respons
ad
mek
inhibitor
cobimetinib
shown
basak
et
al
induc
quiescent
isc
popul
combin
interestingli
cobimetinib
alon
significantli
alter
paneth
cell
differenti
gave
differ
result
combin
fig
next
sought
test
whether
regul
cell
cycl
via
mitogen
signal
may
import
downstream
mediat
follow
inhibit
inhibit
palbociclib
alon
combin
alter
paneth
cell
differenti
supp
fig
inhibit
aurora
kinas
b
significantli
increas
paneth
cell
differenti
notabl
also
lowereffect
size
hit
primari
screen
supp
fig
combin
experi
suggest
sineinduc
stress
respons
may
mediat
suppress
mitogen
signal
depend
erk
enhanc
erk
inhibit
addit
nonexporterrel
action
cell
cycl
interact
aurora
kinas
may
contribut
observ
prodifferenti
effect
total
analys
suggest
inhibit
drive
paneth
cell
enrich
modul
cell
state
within
cycl
isc
stem
ii
iii
modul
includ
confluenc
panepitheli
stress
respons
suppress
mitogen
signal
within
stem
ii
iii
observ
cycl
stem
popul
becom
transient
quiescent
therebi
favor
differenti
toward
paneth
enterocyt
lineag
latter
shortliv
popul
rel
former
balanc
transit
matur
lineag
quiescent
stem
pool
stem
fig
base
understand
inhibit
stemenrich
organoid
hypothes
sine
compound
may
select
enrich
epithelium
paneth
cell
vivo
find
organoid
suggest
sine
treatment
independ
nich
cue
wnt
notch
act
specif
cycl
stem
cell
abund
epitheli
crypt
inhibit
may
enrich
paneth
cell
enterocyt
virtu
rel
long
paneth
cell
lifespan
ireland
et
al
would
expect
longerterm
accumul
paneth
cell
vivo
rel
enterocyt
addit
inhibit
organoid
expand
stem
cell
pool
rather
rebal
pattern
differenti
expect
increas
paneth
cell
number
follow
sine
treatment
vivo
restrict
spatial
constraint
nonhypertroph
crypt
proport
initi
number
cycl
progenitor
suggest
vivo
increas
paneth
cell
number
may
modest
thu
requir
particularli
sensit
method
quantif
follow
similar
protocol
previous
report
sine
treatment
context
cancer
arango
et
al
azmi
et
al
hing
et
al
zheng
et
al
kpt
administ
dose
mgkg
via
oral
gavag
everi
day
twoweek
span
wildtyp
mice
bodi
weight
monitor
clear
toxic
within
treatment
group
observ
signific
weight
loss
indic
toxic
supp
fig
given
anim
weight
loss
standard
chemotherapeut
dosag
regimen
addit
evid
sustain
dosag
sine
advers
impact
cell
popul
tyler
et
al
sought
explor
dose
regimen
well
mgkg
assess
propaneth
phenotyp
may
exist
potenti
toxic
repeat
twoweek
studi
oral
gavag
everi
day
dose
correspond
mgkg
mgkg
mgkg
decreas
mgkg
dose
convent
use
cancer
set
paneth
cell
number
qualiti
known
physiolog
chang
along
length
small
intestin
diseas
associ
paneth
cell
frequent
present
distal
abraham
cho
sought
profil
inhibit
may
differenti
affect
proxim
distal
small
intestin
track
anim
weight
everi
day
collect
proxim
distal
third
small
intestin
day
histolog
quantif
paneth
stem
goblet
popul
fig
lowerdos
regimen
observ
signific
chang
anim
weight
suggest
outsid
gross
toxic
rang
supp
fig
paneth
cell
count
within
well
preserv
crypt
least
crypt
quantifi
per
anim
repres
imag
supp
fig
count
averag
compellingli
within
lower
dose
regimen
observ
signific
increas
paneth
cell
abund
proxim
distal
small
intestin
dose
mgkg
proxim
mgkg
addit
quantifi
abund
stem
cell
well
pa
goblet
cell
within
anim
ascertain
whether
effect
sine
treatment
restrict
paneth
cell
compart
repres
imag
supp
fig
e
interestingli
observ
signific
increas
stem
cell
within
distal
si
dose
correspond
group
greatest
increas
paneth
cell
fig
suggest
potenti
expans
stem
cell
nich
commensur
increas
paneth
cell
abund
identifi
signific
chang
developmentallyrel
goblet
cell
popul
fig
total
data
suggest
sinetreat
may
meaning
approach
specif
increas
paneth
cell
abund
vivo
valid
framework
use
model
organoid
differenti
small
molecul
screen
demonstr
employ
phenotyp
small
molecul
screen
ration
physiolog
motiv
organoid
model
uncov
novel
biolog
target
clinicallyrelev
small
molecul
translat
inform
vivo
tissu
stem
cell
biolog
approach
small
molecul
phenotyp
screen
enabl
specif
function
readout
dynam
heterogen
organoid
model
approach
provid
perturb
capac
nearli
two
order
magnitud
greater
exist
exampl
nongenet
perturb
organoid
model
therebi
enabl
screen
within
space
annot
small
molecul
librari
empow
novel
biolog
target
discoveri
use
model
focus
differenti
specif
lineag
paneth
cell
abl
resolv
pathway
compound
direct
isc
fate
decis
drive
subtl
signific
effect
vivo
tissu
identifi
seri
compoundsknown
inhibit
nuclear
export
act
cycl
isc
induc
program
stress
respons
decreas
mitogen
signal
isc
respons
rebal
selfrenew
differenti
toward
paneth
cell
differenti
recent
work
mitogen
stress
respons
control
reentri
cell
cycl
may
provid
import
context
necess
overlap
two
respons
yang
et
al
specif
mother
cell
transmit
protein
transcript
daughter
cell
base
abund
transmit
signal
either
immedi
reenter
cell
cycl
commit
quiescent
state
transit
quiescenc
prolifer
within
isc
nich
import
role
tissu
homeostasi
regener
quiescent
pool
cryptresid
adjac
cell
serv
reserv
popul
upon
injurydepend
deplet
cycl
stem
cell
reestablish
cycl
progenitor
maintain
homeostat
tissu
regener
ayyaz
et
al
yousefi
et
al
glal
et
al
zhou
et
al
may
one
way
access
observ
respons
therapeut
use
inhibit
inher
pleiotrop
mani
possibl
lead
consid
downstream
mediat
within
isc
drive
observ
shift
fate
decis
make
futur
work
explor
mani
complex
interact
effect
warrant
addit
explor
potenti
local
cellular
nich
describ
stem
ii
iii
within
perturb
evolv
organoid
may
provid
great
clariti
extent
organoid
stem
nich
recapitul
vivo
previous
shown
event
symmetrybreak
wellmodel
within
intestin
organoid
spatial
structur
import
cell
fate
decis
serra
et
al
tool
profil
kind
chang
present
limit
becom
increasingli
avail
studi
natur
better
illumin
biolog
target
may
better
translat
larg
tissu
effect
vivo
author
jmk
rl
hold
equiti
frequenc
therapeut
compani
option
licens
ip
gener
jmk
rl
may
benefit
financi
ip
licens
valid
interest
jmk
rl
review
subject
manag
plan
overseen
institut
accord
conflict
interest
polici
studi
perform
anim
protocol
approv
massachusett
institut
technolog
mit
committe
anim
care
proxim
distal
small
intestin
isol
wildtyp
mice
sex
age
one
six
month
experi
small
intestin
crypt
isol
previous
describ
briefli
small
intestin
harvest
open
longitudin
wash
icecold
dulbecco
phosphat
buffer
salin
without
calcium
chlorid
magnesium
chlorid
sigmaaldrich
clear
lumin
content
tissu
cut
mm
piec
scissor
wash
repeatedli
gentli
pipet
fragment
use
pipett
supernat
clear
fragment
rock
ice
crypt
isol
buffer
mm
edta
life
technolog
min
isol
buffer
remov
fragment
wash
cold
pipet
releas
crypt
cryptcontain
fraction
combin
pass
cell
strainer
bd
bioscienc
centrifug
rcf
min
cell
pellet
resuspend
basal
cultur
medium
mm
glutamax
thermo
fisher
scientifc
mm
hepe
life
technolog
advanc
invitrogen
centrifug
rcf
min
remov
singl
cell
crypt
cultur
matrigel
cultur
system
describ
small
intestin
crypt
medium
supplement
life
technolog
supplement
life
technolog
mm
nacetyllcystein
sigmaaldrich
basal
cultur
medium
supplement
differenti
factor
penstrep
ad
first
four
day
cultur
postisol
small
intestin
crypt
cultur
previous
describ
briefli
crypt
resuspend
basal
cultur
medium
ratio
membran
matrix
gfr
fisher
scientif
plate
center
well
plate
follow
matrigel
polymer
crypt
cultur
medium
enrcv
contain
growth
factor
egf
ngml
life
technolog
noggin
ngml
peprotech
rspondin
ngml
peprotech
small
molecul
lc
laboratori
selleckchem
valproic
acid
mm
sigmaaldrich
ad
well
rock
inhibitor
r
system
ad
first
two
day
isc
cultur
cell
cultur
medium
chang
everi
day
day
cultur
crypt
organoid
expand
enrich
isc
enrcv
condit
expand
isc
passag
everi
day
enrcv
condit
day
cultur
enrcv
condit
isc
differenti
paneth
cell
briefli
isc
cultur
gel
medium
homogen
via
mechan
disrupt
centrifug
rcf
min
supernat
remov
pellet
resuspend
basal
cultur
medium
repeatedli
cloudi
matrigel
almost
gone
last
repeat
pellet
resuspend
basal
cultur
medium
number
organoid
count
centrifug
rcf
min
cell
pellet
resuspend
basal
cultur
medium
ratio
matrigel
plate
center
well
plate
organoidswel
follow
matrigel
polymer
crypt
cultur
medium
enrcv
ad
well
cell
cultur
medium
chang
everi
day
depend
seed
densiti
plate
highthroughput
screen
iscenrich
organoid
passag
split
singl
cell
tyrpl
thermo
fisher
scientif
cultur
day
enrcvi
prior
transfer
plate
cultur
system
prepar
plate
cellladen
matrigel
media
homogen
via
mechan
disrupt
centrifug
rcf
min
supernat
remov
pellet
wash
spun
basal
cultur
medium
repeatedli
cloudi
matrigel
cell
pellet
gone
final
wash
pellet
resuspend
basal
cultur
medium
number
organoid
count
cell
pellet
resuspend
enrcd
medium
plate
first
fill
matrigel
basal
media
coat
well
use
tecan
evo
liquid
handl
deck
allow
gel
minut
cellladen
media
plate
center
well
plate
liquid
handler
plate
spun
rcf
minut
emb
organoid
matrigel
surfac
compound
librari
pin
prep
cell
plate
use
nl
pin
mediawel
cell
cultur
six
day
enrcd
medium
supplement
test
compound
media
chang
three
day
day
six
lysozym
secret
cell
viabil
assess
use
lysozym
assay
kit
enzchek
celltiterglo
ctg
cell
viabil
assay
promega
respect
accord
manufactur
protocol
briefli
screen
plate
wash
fluorobrit
basal
media
mm
glutamax
mm
hepe
fluorobrit
dmem
thermo
fisher
scientif
use
biotek
plate
washer
min
incub
follow
min
centrifug
rcf
settl
media
wash
remov
third
wash
nonstimul
fluorobrit
basal
media
ad
screen
well
use
tecan
evo
liquid
handl
deck
nonstimul
treatment
master
plate
plate
incub
min
minut
top
media
well
screen
plate
transfer
nonstimul
lyz
assay
plate
contain
dq
lyz
assay
work
solut
use
tecan
evo
liquid
handl
deck
nonstimul
lyz
assay
plate
cover
shaken
min
incub
min
fluoresc
measur
shake
nm
use
tecan
plate
reader
media
transfer
nonstimul
lyz
assay
plate
remain
media
remov
screen
plate
stimul
fluorobrit
basal
media
supplement
cch
ad
screen
well
use
tecan
evo
liquid
handl
deck
stimul
treatment
master
plate
plate
incub
min
minut
top
media
well
screen
plate
transfer
stimul
lyz
assay
plate
contain
dq
lyz
assay
work
solut
use
tecan
evo
liquid
handl
deck
stimul
lyz
assay
plate
cover
shaken
min
incub
min
fluoresc
measur
shake
nm
use
tecan
plate
reader
final
ctg
ad
well
screen
plate
shaken
min
room
temperatur
luminesc
read
shake
integr
time
measur
atp
primari
screen
perform
use
target
select
inhibitor
librari
selleck
chem
assay
perform
triplic
use
four
compound
concentr
custom
r
script
pipelin
use
analysi
screen
result
result
excel
csv
file
convert
data
frame
contain
raw
assay
measur
correspond
metadata
plate
posit
treatment
dose
cell
type
stimul
raw
valu
transform
loess
normal
appli
plate
assay
remov
systemat
error
columnrowedg
effect
use
formula
mpindi
et
al
loess
fit
result
transform
valu
row
column
j
valu
loess
smooth
data
row
column
j
calcul
use
r
loess
function
span
follow
loess
normal
platewis
fold
chang
fc
calcul
perform
well
normal
plate
across
experi
calcul
subtract
median
plate
control
loess
normal
valu
replic
strictli
standard
mean
differ
ssmd
use
determin
statist
effect
size
treatment
assay
treatment
dose
group
replic
rel
plate
use
formula
robust
uniformli
minim
varianc
unbias
estim
umvu
zhang
si
respect
sampl
mean
standard
deviat
dij
dij
fc
ith
treatment
jth
plate
gamma
function
adjust
factor
equal
median
provid
stabl
estim
varianc
wi
weight
equal
constraint
wi
n
replic
number
mean
fc
arithmet
mean
sampl
group
treatment
dose
across
replic
use
determin
zscore
treatment
dose
formula
sdpop
standard
deviat
meanfc
calcul
statist
combin
one
final
data
tabl
export
csv
file
hit
identif
primari
screen
hit
defin
ssmd
lyz
assay
greater
optim
critic
valu
top
normal
distribut
fc
valu
assay
zscore
cutoff
hit
treatment
thu
select
wellpow
statist
effect
size
well
strong
biolog
effect
size
optim
dose
per
hit
treatment
determin
ssmd
lyz
assay
confirmatori
secondari
screen
primari
hit
perform
use
plate
method
screen
conduct
replic
base
media
enrcd
media
supplement
compound
day
day
well
replic
per
dose
four
differ
dose
twofold
twofold
fourfold
optim
final
dose
respect
treatment
addit
plate
carri
larg
number
enrdmso
enrcddmso
vehicl
control
well
atp
lyzn
lyz
robust
normal
atp
nonstimul
lysozym
activ
cchstimul
lysozym
activ
measur
collect
data
process
custom
rscript
per
primari
screen
slight
modif
valu
transform
platewis
fc
calcul
well
base
median
valu
enrcddmso
vehicl
control
well
normal
plate
plate
variabl
follow
formula
use
small
intestin
si
collect
mice
divid
three
part
proxim
distal
si
kept
pb
medial
si
discard
si
open
longitudin
wash
pb
si
roll
use
swissrol
techniqu
incub
neutral
buffer
formalin
vwr
h
rt
fix
tissu
embed
paraffin
section
mount
slide
immunohistochemistri
slide
deparaffin
antigen
retriev
use
heatinduc
epitop
retriev
min
use
citrat
buffer
ph
probe
appropri
antibodi
follow
dab
stain
antibodi
lysozym
purchas
abcam
bd
bioscienc
cell
signal
technolog
mcmanu
period
acid
schiff
pa
reaction
slide
deparaffin
oxid
period
acid
stain
schiff
reagent
poli
scientif
follow
counterstain
harri
hematoxylin
slide
scan
aperio
slide
scanner
leica
cell
count
aperio
eslid
manag
slide
blind
random
count
cell
type
count
wellpreserv
crypt
along
longitudin
cryptvillu
axi
singlecel
suspens
obtain
organoid
cultur
either
enrcd
enrcd
nm
differenti
time
cours
detail
fig
briefli
organoid
sampl
harvest
pool
matrigel
dome
total
organoid
per
sampl
excess
matrigel
remov
per
previous
describ
wash
protocol
organoid
resuspend
trypl
min
vigor
homogen
pipett
tip
everi
min
min
suspens
pass
um
cell
strainer
twice
count
brightfield
microscopi
trypan
blue
stain
viabl
singl
cell
util
seqwel
massiv
parallel
scrnaseq
full
method
publish
hugh
et
al
avail
shalek
lab
websit
wwwshaleklabcom
briefli
cell
load
onto
functionalizedpolydimethylsiloxan
pdm
array
preload
uniquelybarcod
mrna
captur
bead
chemgen
cell
settl
well
array
seal
hydroxyl
polycarbon
membran
pore
size
nm
facilit
buffer
exchang
confin
biolog
molecul
within
well
follow
membranes
buffer
exchang
across
membran
permit
cell
lysi
mrna
transcript
hybrid
bead
bead
remov
proceed
revers
transcript
obtain
beadbound
cdna
product
underw
exonucleas
treatment
new
england
biolab
remov
excess
primer
proceed
second
strand
synthesi
follow
exonucleas
treatment
bead
mix
naoh
min
room
temperatur
denatur
mrnacdna
hybrid
product
bead
second
strand
synthesi
perform
mastermix
consist
maxima
rt
buffer
solut
dntp
dnsmart
oligo
klenow
exo
di
ultrapur
water
ad
bead
incub
hour
endoverend
rotat
second
strand
synthesi
pcr
amplif
perform
use
kapa
hifi
pcr
mix
kapa
biosystem
specif
pcr
mastermix
consist
ul
kapa
mastermix
ul
um
ispcr
oligo
ul
nucleasefre
water
combin
bead
per
reaction
follow
pcr
amplif
whole
transcriptom
product
isol
two
round
spri
purif
use
ampur
spri
bead
beckman
coulter
inc
volumetr
ratio
quantifi
use
qubit
sequenc
librari
construct
whole
transcriptom
product
use
nextera
tagment
method
total
pg
pool
cdna
librari
per
sampl
tagment
amplifi
sequenc
purifi
two
round
spri
purif
volumetr
ratio
yield
librari
size
averag
distribut
base
pair
length
determin
use
agil
screen
tape
system
agil
genom
array
sequenc
within
multisampl
pool
illumina
novaseq
broad
institut
walkup
sequenc
core
read
structur
pair
end
read
start
custom
read
primer
contain
base
cell
barcod
uniqu
molecular
identifi
umi
read
base
contain
transcript
inform
sequenc
read
align
perform
use
version
dropseq
pipelin
previous
describ
macosko
et
al
novaseq
sequenc
run
raw
sequenc
read
convert
bcl
file
fastq
use
base
nextera
indic
correspond
individu
sampl
demultiplex
fastq
align
genom
use
star
dropseq
pipelin
cloudcomput
platform
maintain
broad
institut
individu
read
tag
barcod
uniqu
molecular
identifi
umi
contain
read
sequenc
fragment
follow
align
read
group
cell
barcod
subsequ
collaps
umi
digit
gene
express
dge
matrix
extract
gener
prior
analysi
dge
matric
preprocess
remov
cellular
barcod
less
uniqu
gene
greater
uniqu
molecular
identifi
umi
correspond
mitochondri
gene
low
outlier
standard
housekeep
gene
express
tirosh
et
al
barcod
greater
umi
cellular
doublet
identifi
manual
inspect
use
doubletfind
algorithm
mcginni
et
al
preprocess
dge
deposit
geo
qualiti
doublet
correct
perform
integr
analysi
combin
dataset
cell
qualiti
metric
gene
number
captur
umi
percent
mitochondri
gene
report
fig
better
control
potenti
batch
effect
may
aris
sampl
handl
librari
prepar
dimension
reduct
cluster
perform
follow
normal
regular
neg
bionom
regress
implement
seurat
via
sctransform
hafemeist
satija
perform
variabl
gene
identif
dimension
reduct
util
first
princip
compon
base
elbow
method
identifi
cell
type
cluster
use
louvain
cluster
resolut
follow
umap
visual
use
lognorm
rna
express
differenti
gene
express
test
gene
set
enrich
analys
gene
modul
score
identifi
gene
enrich
across
cluster
use
wilcoxon
rank
sum
test
gene
express
least
cell
minimum
logfold
chang
identifi
gener
cell
type
corrobor
cell
type
ident
rel
gene
signatur
come
establish
murin
small
intestin
scrnaseq
atla
haber
et
al
gene
modul
score
within
cell
base
enrich
gene
set
express
rel
randomli
select
gene
compar
express
level
cell
tirosh
et
al
via
addmodulescor
function
within
seurat
addit
celltyp
modul
score
haber
et
al
incorpor
gene
set
isc
subtyp
biton
et
al
addit
gene
set
repres
isc
activ
basak
et
al
gene
known
contain
ne
valid
databas
fu
et
al
quantifi
enrich
cell
popul
treatment
control
within
dataset
util
fisher
exact
test
cell
type
rel
other
timepoint
consid
popul
test
cell
type
account
least
cell
control
sampl
present
rel
enrich
deplet
cell
popul
treatment
time
odd
ratio
correspond
confid
interv
fdradjust
p
valu
signific
denot
correspond
figur
legend
gene
set
enrich
analysi
gsea
perform
full
rankord
list
differentiallyexpress
gene
without
foldchang
p
valu
cutoff
use
piano
r
packag
et
al
msigdb
hallmark
gene
set
liberzon
et
al
subramanian
et
al
gene
set
least
match
gene
consid
gene
set
fdrcorrect
p
valu
retain
methodolog
statist
analysi
screen
detail
subsequ
experi
replic
type
number
report
correspond
figur
legend
along
statist
test
perform
either
classif
cohen
effect
size
classif
p
valu
supplement
inform
describ
avail
upon
request
singlecel
rna
sequenc
data
report
paper
made
avail
shortli
geo
supplementari
tabl
result
primari
secondari
lysozym
lyz
secret
screen
group
compound
dose
report
fold
chang
fc
standard
z
score
strictli
standard
mean
differ
ssmd
marker
gene
organoid
differenti
time
cours
singlecel
rnaseq
determin
wilcoxon
differenti
express
test
cluster
versu
rest
differenti
express
gene
gene
set
enrich
analysi
gsea
differenti
express
gene
treat
untreat
stem
ii
iii
cell
day
organoid
differenti
time
cours
singlecel
rnaseq
violin
plot
singlecel
rnaseq
log
normal
transcript
per
express
untreat
control
cell
split
nonstem
stem
ii
iii
annot
wilcoxon
rank
sum
test
bonferroni
correct
stem
ii
iii
vs
nonstem
p
b
violin
plot
modul
score
cell
deriv
gene
known
nuclear
export
signal
ne
untreat
control
cell
split
nonstem
stem
ii
iii
annot
score
scale
rang
oneway
anova
posthoc
dunnett
multipl
comparison
test
p
p
p
c
time
cours
treatment
enrcd
differenti
organoid
treatment
everi
continu
interv
flow
cytometri
analys
intestin
organoid
treat
indic
time
frame
day
cultur
enrcd
media
paneth
cell
identifi
lysozymeposit
cell
mean
individu
valu
shown
dot
line
repres
averag
paneth
cell
fraction
control
sampl
oneway
anova
posthoc
dunnett
multipl
comparison
test
p
p
p
e
volcano
plot
differenti
express
singlecel
rnaseq
log
normal
gene
control
cell
within
stem
ii
iii
popul
earli
timepoint
day
red
point
enrich
grey
enrich
control
differenti
express
base
wilcoxon
rank
sum
test
signific
fold
chang
base
standard
deviat
gene
fdr
bonferroni
correct
cutoff
p
f
gene
set
enrich
analysi
gsea
normal
enrich
score
differenti
express
gene
control
cell
within
stem
ii
iii
popul
earli
timepoint
day
gene
set
shown
msigdb
hallmark
fdr
red
enrich
grey
enrich
control
g
split
violin
plot
control
modul
score
cell
deriv
significantli
enrich
stress
respons
deplet
mitogen
signal
gene
control
cell
within
stem
ii
iii
popul
earli
timepoint
day
score
scale
rang
effect
size
cohen
modul
control
within
cell
type
repres
bar
chart
violin
plot
h
violin
plot
modul
score
deriv
gene
express
activ
quiescent
intestin
stem
cell
control
cell
within
stem
ii
iii
popul
earli
timepoint
day
score
scale
rang
twosid
test
p
lyz
secret
assay
organoid
differenti
enrcd
treat
inhibitor
nm
cobimetinib
mek
inhibitor
day
organoid
incub
fresh
basal
media
without
carbachol
cch
h
day
data
normal
atp
abund
standard
control
experi
mean
individu
valu
shown
dot
line
repres
control
valu
oneway
anova
posthoc
tukey
multipl
comparison
test
p
p
j
propos
mechan
inhibit
drive
transcript
chang
manifest
increas
stress
respons
reduc
mitogen
signal
result
rebalanc
cycl
stem
cell
fate
decis
toward
secretori
paneth
cell
absorpt
enterocyt
